PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

Oxymatrine targeted nanoliposomes

Inquiry

Cat. No.: X26-05-ZQ1036

Oxymatrine targeted nanoliposomes

Name: Oxymatrine targeted nanoliposomes
SKU: X26-05-ZQ1036

Inquiry

Synonym: Oxymatrine targeted NLs; Targeted oxymatrine nanoliposomes; Oxymatrine-loaded targeted NLs

Product Size

100 mg; 250 mg; 500 mg; 1 g; 5 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

This formulation provides oxymatrine targeted nanoliposomes engineered for highly selective surface interactions. The nanostructures are composed of a fluid-phase phospholipid bilayer into which specific affinity ligands are chemically integrated. The water-soluble quinolizidine alkaloid oxymatrine is encapsulated within the central aqueous reservoir of the spherical vesicles. The small particle diameter and specific ligand arrangement are carefully maintained to optimize structural uniformity and molecular recognition capabilities.

Source

Custom synthesis

Functional Group

Oxymatrine

Form

Solid or powder

Purity

≥95%

Impurities

No visible impurities to the naked eye.

Identity

HPLC/MS/NMR

Publications

Publications (0)

Publications

×

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.